0001288123-18-000016.txt : 20180622
0001288123-18-000016.hdr.sgml : 20180622
20180622123649
ACCESSION NUMBER: 0001288123-18-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180620
FILED AS OF DATE: 20180622
DATE AS OF CHANGE: 20180622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Corvese Brian
CENTRAL INDEX KEY: 0001393207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 18913944
MAIL ADDRESS:
STREET 1: C/O ANTIGENICS INC.
STREET 2: 162 FIFTH AVENUE, SUITE 900
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-06-20
0
0001098972
AGENUS INC
AGEN
0001393207
Corvese Brian
C/O AGENUS INC.
149 FIFTH AVENUE, SUITE 500
NEW YORK
NY
10010
1
0
0
0
Stock Option, right to buy
5.65
2018-06-20
4
A
0
37500
5.65
A
2019-03-02
2028-03-02
Common Stock
37500
37500
D
Restricted Stock Unit
2018-06-20
4
A
0
21276
A
2019-04-19
2019-04-19
Common Stock
21276
21276
D
Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, vesting on March 2, 2019.
RSU was granted on April 19, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Award vests on April 19, 2019.
Christine M. Klaskin, by Power of Attorney
2018-06-22